Merck & Co., Inc. is 145.8x more valuable than Aurinia Pharmaceuticals Inc. by market capitalization ($293.16 B vs $2.01 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AUPH | MRK |
|---|---|---|
| Market cap | $2.01 B | $293.16 B |
| US-listed rank | #2095 | #44 |
| Revenue (latest FY) | $283.06M | $65.01B |
| Net income (latest FY) | $287.20M | $18.25B |
| Net margin | 101.5% | 28.1% |
| P/E (trailing FY) | 7.0 | 16.1 |
| SEC filings | 595 | 996 |
Merck & Co., Inc. is 145.8x more valuable than Aurinia Pharmaceuticals Inc. by market capitalization ($293.16 B vs $2.01 B).
In their latest fiscal years, Aurinia Pharmaceuticals Inc. reported $283.06M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: Aurinia Pharmaceuticals Inc. and Merck & Co., Inc., or browse the full rankings.